Abstract 11820: A Meta-Analysis of Efficacy and Safety of the New Generation Watchman FLX Device Compared to the Watchman 2.5

Authors

Mostafa R. Zaalouk, Rochester Regional HealthFollow
Mohamed Eid, Rochester Regional HealthFollow
Ahmad Al-Abdouh, Saint Agnes Hospital, Baltimore, MD
Mahmoud Ismayl, Creighton University School of Medicine, Omaha, NE
Sarah Mohamed
Sarath Lal Mannumbeth Renjithal, Rochester Regional HealthFollow
Mahmood Mubasher, Rochester Regional HealthFollow
Mamas A. Mamas, Keele University, Stoke-on-Trent, United Kingdom

Department

Medicine

Document Type

Conference Proceeding

Publication Title

Circulation

Conference Name

American Heart Association Scientific Sessions

Conference Date

2022-11-05 - 2022-11-07

First Page

A11820

DOI

10.1161/circ.146.suppl_1.11820

Volume

146

Issue

Suppl_1

Publication Date

11-8-2022

Comments

INTERVENTIONAL TREATMENTS

SESSION TITLE: THE LATEST AND THE GREATEST RESEARCH ON LEFT ATRIAL APPENDAGE PROCEDURES

Recommended Citation

Zaalouk, M. R., Eid, M., Al-Abdouh, A., Ismayl, M., Mohamed, S., Mannumbeth Renjithal, S. L., Mubasher, M., & Mamas, M. A. (2022). Abstract 11820: A Meta-Analysis of Efficacy and Safety of the New Generation Watchman FLX Device Compared to the Watchman 2.5. Circulation, 146 (Suppl_1), A11820. https://doi.org/10.1161/circ.146.suppl_1.11820